(SONN) – What’s Occurring With Sonnet BioTherapeutics Inventory?

(SONN) - What's Happening With Sonnet BioTherapeutics Stock?

  • Buying and selling of Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) inventory was halted thrice in the course of the early morning session.
  • No company-specific reviews are driving up the inventory value at the moment, so it seems there are exterior elements at play.
  • Discussions about Sonnet have floated on social media platforms like StockTwits, Twitter, and Discord. 
  • Buyers on these platforms are citing the Firm as being a brief squeeze candidate. 
  • The clinical-stage biotech firm centered on most cancers therapeutics reported its Q3 FY21 outcomes early this week. 
  • Worth Motion: SONN shares are up 151.0% at $1.87 in the course of the market session on the final test Thursday.